human
anim
constantli
inocul
variou
microorgan
resid
upper
respiratori
tract
inhal
aerosol
yet
pneumonia
rel
rare
event
impli
exist
effici
defens
mechan
capabl
elimin
vast
major
microorgan
colon
multipli
suffici
level
result
clinic
diseas
order
overcom
continu
barrag
microorgan
complex
array
defens
mechan
present
upper
lower
respiratori
tract
capabl
clear
organ
howev
individu
suffer
varieti
diseas
includ
viru
infect
colon
occur
rapidli
subsequ
develop
pneumonia
thu
estim
bacteri
pneumonia
develop
viral
infect
furthermor
individu
suffer
viral
pneumonia
chanc
develop
bacteri
pneumonia
jakab
reason
increas
colon
lung
bacteria
follow
viru
infect
shown
relat
surfac
properti
epitheli
cell
line
respiratori
tract
physiolog
environ
respiratori
tract
well
alter
specif
nonspecif
defens
mechan
lung
occur
result
viru
infect
condit
allow
greater
number
bacteria
adher
surfac
cell
possibl
replic
faster
rate
overcom
nonspecif
defens
mechan
present
respiratori
tract
present
review
attempt
indic
virus
enhanc
bacteri
colon
adher
respiratori
epitheli
tissu
virus
alter
specif
nonspecif
defens
mechan
respiratori
tract
allow
newli
adher
bacteria
replic
overcom
compromis
defens
mechan
addit
discuss
host
defens
mechan
attempt
clear
virus
bacteria
lead
immunopatholog
increas
replic
rate
bacteria
aid
develop
pneumonia
final
discuss
potenti
way
reduc
viral
bacteri
respiratori
infect
immun
use
variou
chemotherapeut
immunomodul
present
develop
although
exampl
use
varieti
differ
human
anim
respiratori
infect
major
emphasi
attempt
provid
unifi
hypothesi
virus
modifi
environment
condit
lung
alter
host
defens
mechan
allow
bacteria
replic
faster
produc
pneumonia
exampl
use
demonstr
specif
event
constru
everi
event
occur
everi
situat
past
year
consider
advanc
made
understand
event
occur
molecular
level
initi
respiratori
diseas
field
sequenc
event
respiratori
infect
whether
caus
rhinovirus
orthomyxovirus
paramyxovirus
adenovirus
coronavirus
etc
rather
similar
order
initi
infect
produc
ill
virus
must
enter
host
come
contact
suscept
tissu
cell
initi
infect
gener
occur
one
two
way
direct
contact
droplet
secret
contain
viru
aerosol
viru
small
aerosol
viru
particl
enter
variou
section
respiratori
tract
includ
lower
respiratori
tract
howev
gener
major
initi
infect
occur
upper
respiratori
tract
immedi
upon
contact
respiratori
epithelium
viru
encount
varieti
nonspecif
defens
mechan
includ
mucu
nonspecif
compound
inhibit
viru
attach
host
cell
epithelium
specif
interact
viru
host
cell
receptor
occur
viru
initi
replic
cycl
gener
induc
lytic
infect
respiratori
epithelium
sinc
virus
infect
upper
respiratori
tract
caus
local
infect
cytopatholog
incub
time
gener
short
one
initi
defens
mechan
respiratori
tract
mucu
may
contain
either
glycoprotein
similar
receptor
molecul
respiratori
epitheli
cell
inde
secret
receptor
glycoprotein
may
interfer
initi
attach
virus
epitheli
cell
virus
possess
specif
enzym
neuraminidas
may
destroy
mucou
glycoprotein
allow
attach
infect
epitheli
cell
furthermor
proteas
present
within
mucu
may
result
cleavag
specif
viru
glycoprotein
requir
infect
choppin
scheid
infect
epitheli
cell
respiratori
tract
occur
viru
replic
ensu
product
larg
number
progeni
virus
either
bud
plasma
membran
epitheli
cell
case
nake
virus
result
lysi
virusinfect
cell
upon
releas
viru
infect
cell
spread
throughout
respiratori
tract
either
celltocel
spread
slow
aerosol
lower
tract
breath
spread
mucu
due
action
result
spread
viru
infect
sinus
bronchi
lower
trachea
lung
occur
chanock
et
al
parrott
et
al
result
may
rapid
vascular
reaction
accumul
transud
exud
cell
debri
inflammatori
cell
result
cellular
degener
environment
condit
establish
conduc
bacteri
cell
attach
growth
see
section
case
even
death
virusinfect
cell
occur
host
epitheli
cell
luxuri
function
may
reduc
may
includ
secret
variou
glycoprotein
mucu
bactericid
factor
consequ
viru
infect
interferon
ifn
produc
releas
extracellular
environ
respiratori
tract
well
system
green
et
az
babiuk
et
az
famili
antivir
molecul
limit
rate
viru
replic
modul
host
defens
viru
superinfect
bacteria
addit
releas
ifn
infect
cell
also
releas
viral
compon
detriment
epitheli
leukocyt
function
see
section
v
vi
bind
attach
bacteria
variou
substrat
within
environ
import
prerequisit
process
colon
attach
bacteria
surfac
cell
mediat
adhesin
present
bacteri
cell
wall
adhesin
protein
bind
specif
glycolipid
glycoprotein
receptor
express
surfac
cell
normark
et
al
attach
bacteria
mucos
surfac
import
initi
step
colin
also
form
basi
infect
product
diseas
pathogen
bacteria
costerton
et
al
beachey
sparl
adher
bacteria
mucos
surfac
complex
phenomenon
involv
virul
factor
includ
adhesin
pathogen
bacteria
well
mucos
surfac
local
immun
epitheli
cell
turnov
mucou
line
layer
babiuk
reid
sobel
express
adhesin
protein
modul
environment
condit
lung
subject
phase
antigen
variat
singl
bacteri
cell
give
rise
progeni
cell
express
adhesin
protein
differ
structur
number
serolog
function
depend
environ
variat
express
adhesin
thought
import
factor
abil
bacteria
adapt
microenviron
evad
primari
host
defens
mechan
haa
et
al
although
type
adhesin
vari
bacteria
fimbra
pilu
lipoteicho
acid
shown
primarili
involv
mediat
adhes
ofek
factor
also
shown
import
adhesin
exampl
filament
hemagglutinin
toxin
bordetella
pertussi
twomanen
weiss
fact
two
adhesin
report
work
concert
process
colon
twomanen
weiss
agglutinogen
b
pertussi
also
shown
uitro
capabl
act
adhesin
redhead
abil
bacteria
produc
one
adhesintyp
protein
n
ad
advantag
bacteria
initi
infect
sinc
time
crucial
bacteria
abl
becom
establish
colon
ofek
state
regul
factor
influenc
phase
variat
growth
cycl
bacteria
microenviron
lung
therefor
add
select
pressur
determin
whether
bacteria
express
one
adhesin
ofek
viru
infect
favor
bacteri
growth
phase
variat
probabl
high
colon
subsequ
pneumonia
ensu
structur
variat
phenotyp
bacteria
also
play
role
bacteri
adher
capsul
product
affect
hydrophob
organ
alter
abil
interact
epitheli
phagocyt
cell
whitnack
et
al
beachey
ofek
et
al
ofek
suggest
product
hyaluron
capsul
interfer
adhes
thu
variat
phenotyp
may
import
pathogenesi
noncapsul
bacteria
initi
infect
result
adher
capabl
establish
becom
capsul
therebi
better
chanc
surviv
prevent
attach
phagocyt
cell
ofek
babiuk
capsul
compos
polysaccharid
also
abil
interfer
adhes
craven
et
al
seling
reed
glorioso
et
al
ofek
point
function
abil
bacteria
adher
host
cell
alway
benefici
bacteria
attach
bacteria
mucos
epithelium
essenti
initi
surviv
pathogen
wherea
attach
bacteria
phagocyt
cell
case
benefit
bacteria
increas
surviv
host
abil
bacteria
chang
express
type
number
adhesin
protein
product
substanc
capabl
interf
attach
may
fundament
import
establish
colon
subsequ
infect
also
mean
circumv
host
defens
mechan
alter
adher
bacteria
may
also
come
extrins
factor
presenc
absenc
dival
cation
shown
zinc
level
alter
bacteri
infect
zinc
reduc
surfac
charg
adhes
enhanc
sugarman
et
al
viral
infect
appear
influenc
adher
colon
bacteria
davison
sandford
fainstein
et
al
sanford
et
al
nugent
pesanti
mechan
virus
alter
bacteri
adher
mani
includ
alter
host
cell
surfac
membran
receptor
alter
microenviron
bacteri
attach
occur
babiuk
viral
infect
alter
level
fibronectin
product
sinc
colon
bacteria
correl
low
fibronectin
level
hyne
bye
wood
may
import
factor
bacteri
colon
cell
death
caus
virus
also
increas
releas
proteas
may
respons
degrad
fibronectin
surfac
innocentbystand
cell
thu
favor
adher
bacteria
produc
proteas
would
capabl
decreas
fibronectin
level
increas
colon
wood
et
al
yamada
weston
mani
medic
import
bacteri
pathogen
produc
iga
proteas
miluzzo
delisl
mulk
plaut
furthermor
mani
proteas
depend
dival
cation
activ
labib
et
al
viral
infect
extens
hemorrhag
tissu
damag
occur
increas
level
dival
cation
result
one
ion
shown
import
bacteri
growth
pathogenesi
iron
hatch
et
al
mile
khimji
certain
bacteria
produc
iron
chelat
ironbind
protein
capabl
trap
iron
requir
growth
furthermor
case
iron
increas
level
adhesin
pili
format
bacteria
babiuk
viru
infect
respiratori
tract
induc
extens
cell
damag
hemorrhag
would
increas
level
iron
dival
cation
would
favor
bacteri
adhes
growth
furthermor
amount
iron
bound
transferrin
shown
critic
immun
regul
matzner
et
al
thu
level
iron
affect
bacteri
adhes
growth
also
host
abil
respond
infect
viral
infect
implic
alter
epitheli
cell
secret
pijoan
et
al
secret
bactericid
activ
therefor
absenc
allow
bacteria
gain
hold
initi
colon
infect
upper
respiratori
tract
microcoloni
form
enter
lower
respiratori
tract
either
aspir
johanson
et
al
reduc
mucociliari
clearanc
jakab
larg
microcoloni
difficult
phagocyt
may
fact
caus
phagocyt
cell
discharg
enzym
contain
granul
caus
surround
tissu
damag
slauson
therebi
creat
better
environ
bacteri
replic
adhes
addit
bacteria
releas
cytotoxin
advers
effect
phagocyt
cell
see
section
vii
induc
cell
death
improv
environ
bacteri
growth
defens
normal
lung
variou
microorgan
mediat
plethora
inflammatori
immun
effector
cell
act
concert
variou
solubl
factor
major
case
cell
obtain
bronchoalveolar
lavag
macrophag
less
neutrophil
hunninghak
et
al
base
find
often
consid
macrophag
major
cell
type
involv
maintain
steril
normal
lung
howev
must
emphas
part
defens
begin
upper
respiratori
tract
initi
interact
host
pathogen
occur
outcom
interact
determin
whether
organ
ever
enter
lung
first
defens
includ
anatom
barrier
mucociliari
clearanc
mechan
reflex
mechan
local
secretori
iga
ironcontain
protein
transferrin
surfactanteven
alveolar
macrophag
becom
involv
earli
surveil
mechan
depend
immunolog
statu
host
except
immunoglobulin
mechan
either
individu
concert
fail
elimin
microorgan
specif
defens
mechan
must
come
play
clear
organ
includ
humor
cellular
immun
respons
well
inflammatori
respons
best
character
influx
polymorphonuclear
granulocyt
pmn
see
tabl
review
discuss
detail
individu
defens
mechan
function
respiratori
tract
prevent
infect
summar
import
defens
mechan
alter
result
viru
infect
therebi
increas
opportun
bacteria
colon
lower
respiratori
tract
caus
pneumonia
advent
bronchioalveolar
lavag
procedur
rapidli
expand
knowledg
past
year
understand
variou
secretori
cellular
compon
lung
normal
individu
varieti
secretori
product
present
variou
level
respiratori
tract
mani
case
secret
contain
complement
compon
transferrin
surfact
fibronectin
immunoglobulin
mostli
variou
humor
factor
act
concert
specif
immunoglobulin
cell
help
destroy
reduc
replic
virus
bacteria
fibronectin
transferrin
surfact
three
substanc
addit
abl
potenti
nonimmun
opson
activ
host
defens
mechan
also
import
alter
rate
adher
bacteri
replic
exampl
fibronectin
fragment
thereof
shown
function
import
enhanc
macrophagemonocyt
phagocytosi
particl
convent
opsonin
also
stimul
macrophag
ingest
opson
particl
czop
et
al
pommier
et
al
transferrin
demonstr
bacteriostat
effect
bacteria
strongli
depen
phagocytosi
kill
bacteria
immunopatholog
superoxid
free
radic
dent
presenc
iron
growth
rankin
reynold
although
mani
studi
conduct
uitro
littl
inform
avail
regard
role
transferrin
lower
respiratori
tract
infect
effect
also
lack
inform
whether
synergist
interact
transferrin
secretori
iga
effect
similar
lactoferrin
breast
milk
action
surfact
reduc
alveolar
surfac
tension
long
appreci
moreov
evid
suggest
surfact
also
facilit
kill
bacteria
alveolar
macrophag
laforc
addit
enhanc
alveolar
macrophag
kill
bacteria
surfact
also
shown
antibacteri
activ
gramposit
bacteria
conrod
yoneda
thu
surfact
appear
abl
reduc
bacteri
growth
two
mechan
direct
kill
activ
cell
antibacteri
activ
summari
respiratori
tract
endow
mani
differ
compon
play
crucial
role
clear
variou
foreign
organ
respiratori
tract
tabl
case
one
factor
import
anoth
relationship
kinet
infect
well
specif
organ
involv
howev
mani
case
specif
factor
act
concert
elimin
organ
quickli
inde
organ
elimin
may
play
import
role
immunopatholog
enhanc
replic
bacteria
evid
interplay
variou
factor
forthcom
studi
wherein
defici
one
singl
compon
may
predispos
individu
recurr
respiratori
tract
infect
specif
follow
viru
infect
specif
nonspecif
defens
compromis
yet
superinfect
bacteria
frequent
occur
probabl
bacteri
superinfect
depend
capac
lung
elimin
bacteria
determin
larg
number
humor
cellular
factor
tabl
dose
viru
bacteria
virul
organ
adequaci
specif
nonspecif
host
defens
mechan
follow
section
discuss
virus
alter
variou
aspect
host
defens
mechan
may
lead
reduc
threshold
level
suscept
bacteria
state
pulmonari
viru
infect
predispos
anim
human
secondari
bacteri
pneumonia
jakab
jakab
loosli
barber
et
al
assum
least
part
result
virusinduc
impair
alveolar
macrophag
function
jakab
lung
distal
ciliat
airway
epithelium
ie
bronchiol
alveoli
resid
monocyt
migrat
alveolar
interstitium
lumen
blood
offer
first
line
defens
invad
microorgan
partli
product
secret
antimicrobi
factor
ifn
bielefeldt
ohmann
et
al
reactiv
oxygen
speci
ro
enzym
partli
direct
cytotox
effector
mechan
includ
phagocytosi
degrad
microbi
agent
addit
may
proinflammatori
function
produc
factor
form
part
activ
part
defens
system
therebi
inhibit
microbi
spread
lead
patholog
lesion
see
slauson
experiment
anim
model
use
variou
respiratori
virus
demonstr
sever
durat
ill
depend
amount
viru
reach
lower
respiratori
tract
yate
et
al
jakab
acut
stage
infect
epitheli
cell
airway
appear
princip
site
viral
replic
yate
jakab
lead
direct
destruct
epithelium
least
obstruct
luxuri
function
cell
oldston
et
al
product
pulmonari
surfaceact
lipoprotein
call
surfact
function
may
thu
indirectli
inhibit
addit
viral
infect
may
direct
suppress
schwartz
christman
opson
effect
juer
et
al
import
especi
phagocytosi
invad
bacteria
immedi
tissu
reaction
viru
infect
product
ifn
modul
variou
macrophag
activ
uiuo
uitro
bielefeldt
ohmann
et
al
addit
viral
infect
may
direct
suppress
effect
popul
affect
function
immunolog
fc
complement
c
nonimmunolog
membran
receptorbind
activ
receptormedi
phagocytosi
phagosomelysosom
fusion
intracellular
kill
bacteri
degrad
review
jakab
well
product
neutrophil
chemotact
factor
mcguir
gadek
hunninghak
although
effect
clearli
evid
follow
uitro
infect
virus
often
appear
discrep
uitro
uiuo
observ
ampli
demonstr
bovin
herpesviru
infect
model
bovin
suscept
infect
uitro
result
impair
immun
receptor
function
antibodydepend
cellmedi
cytotox
adcc
contrast
less
retriev
experiment
infect
calv
product
infect
neither
adcc
receptor
function
appear
alter
least
transient
bielefeldt
ohmann
babiuk
fact
appear
select
stimul
occur
infect
rather
compromis
function
activ
bielefeldt
ohmann
babiuk
well
select
inhibit
function
adcc
chemotaxin
product
gener
bielefeldt
ohmann
babiuk
mcguir
babiuk
whether
dispar
viral
effect
directli
indirectli
induc
caus
select
effect
activ
popul
whole
ascrib
differenti
effect
subpopul
bielefeldt
ohmann
et
al
vari
function
activ
remain
investig
whatev
explan
might
function
alter
popul
may
play
benefici
role
well
contribut
lung
injuri
via
proinflammatori
activ
monocyt
avid
prcducer
complement
compon
tissu
factor
mcgee
rothenberg
plateletaggreg
factor
roubin
et
al
arachidon
acid
deriv
larson
henson
neutral
proteas
unanu
factor
may
contribut
increas
vascular
permeabl
coagul
fibrinolysi
tissu
damag
bevilacagva
et
al
till
et
al
slauson
see
therebi
creat
environ
promot
secondari
bacteri
invas
growth
time
interfer
normal
clearanc
mechan
newhous
et
al
virushost
system
tempor
relationship
viru
replic
lung
develop
specif
immun
suppress
pulmonari
bactericid
activ
note
led
suggest
depress
function
viral
infect
may
due
immunopatholog
mechan
jakab
jakab
warr
astri
jakab
case
viral
infect
eg
influenza
viru
pneumonia
challeng
certainli
applic
viruslung
defens
relationship
yate
et
al
pmn
may
play
crucial
role
clearanc
bacteria
lower
respiratori
airway
pmn
recruit
induc
within
hour
bacteri
invas
probabl
mediat
combin
effect
epitheli
endothelialderiv
chemotact
factor
includ
complement
fragment
thromboxan
leukotrien
davi
et
al
larsen
henson
howev
prior
lung
infect
viru
delay
recruit
mcguir
babiuk
thu
perhap
give
bacteria
enough
time
multipli
number
eventu
overwhelm
variou
defens
mechan
andor
caus
sever
inflamm
progress
circulu
vitiousu
delay
pmn
immigr
may
caus
either
suppress
product
amderiv
chemotact
factor
mcguir
babiuk
direct
suppress
effect
viru
migratori
activ
pmn
ruutu
et
al
bultman
gruler
bultman
et
al
indirectli
via
induct
product
ifn
arachidon
acid
deriv
variou
cell
type
lung
bielefeldt
ohmann
babiuk
davi
et
al
final
taken
consider
circul
pmn
pool
may
alreadi
deplet
readili
migrat
cell
due
virusinduc
pmn
migrat
alveoli
yourte
et
al
time
secondari
bacteri
invas
occur
scenario
seem
conceiv
light
neutropenia
often
occur
follow
viru
infect
respiratori
tract
yate
bale
et
al
whether
function
pmn
affect
viru
infect
seem
vari
among
variou
virushost
system
influenza
viru
infect
report
caus
depress
chemiluminesc
measur
respiratori
burst
bactericid
activ
pmn
wherea
phagocytosi
remain
unaffect
abramson
et
al
abramson
et
al
contrast
superoxid
anion
product
peripher
blood
pmn
significantli
increas
infect
cattl
bielefeldt
ohmann
bovin
viral
diarrhea
viru
bvdv
also
report
suppress
pmnmediat
bacteri
defens
roth
et
al
reggiardo
kaeberl
roth
kaeberl
human
except
delay
impair
chemotaxi
consist
abnorm
pmn
function
found
mild
influenza
martin
et
al
whether
sever
influenza
infect
human
similar
suppress
effect
speci
remain
determin
furthermor
exclud
migrat
lung
antibacteri
function
pmn
may
suppress
local
produc
factor
ifn
prostaglandin
bielefeldt
ohmann
babiuk
davi
et
al
partial
autoinactiv
myeloperoxidas
ro
releas
pmn
weber
et
al
stendahl
et
al
baehner
et
al
mill
et
al
kobayashi
et
al
voetman
et
al
addit
affect
nonspecif
defens
mani
viral
infect
also
caus
suppress
specif
immun
defens
mechan
although
mani
mechan
virus
suppress
immun
respons
fulli
understood
attempt
made
section
discuss
alter
immun
system
clearli
modifi
follow
viru
infect
known
mani
case
suppress
immun
respons
due
alter
function
activ
effector
cell
impair
caus
either
direct
viruseffector
cell
interact
indirectli
releas
suppressor
molecul
varieti
cell
respons
viru
infect
friedman
et
al
although
exact
role
lymphocyt
prevent
recoveri
primari
viral
bacteri
infect
lung
clearli
known
consider
amount
evid
viral
infect
advers
affect
lymphocyt
function
studi
use
mitogendriven
lymphocyt
prolifer
assay
virus
shown
reduc
lymphocyt
respons
maxim
suppress
often
occur
time
host
suscept
secondari
bacteri
infect
loss
respons
may
due
number
paramet
includ
induct
tsuppressor
cell
tsuppressor
cell
factor
suppress
like
tcell
subset
depend
expand
bensussan
et
al
tsuppressor
cell
must
therefor
abl
suppress
antigenspecif
thelper
respons
also
induc
product
thelper
cell
herbert
watson
respiratori
viru
cattl
observ
cattl
infect
product
peak
time
maxim
immunosuppress
observ
make
exist
bhvlspecif
tsuppressor
cell
highli
probabl
point
factor
distinct
isol
shown
induc
tsuppressor
cell
prolifer
kasakura
human
herpesvirus
also
shown
induc
suppressor
cell
activ
horohov
et
az
suppressor
cell
also
implic
depress
cellmedi
immun
respons
follow
infect
influenza
respiratori
syncyti
viru
robert
bhvlinduc
respiratori
infect
lymphocyt
respons
lectin
becom
significantli
suppress
remain
suppress
state
day
challeng
bielefeldt
ohmann
filion
et
al
furthermor
decreas
lymphocyt
respons
restor
addit
exogen
state
earlier
although
anim
appear
produc
higher
level
follow
infect
lymphocyt
virusinfect
anim
respons
number
reason
lack
reactiv
exist
name
downregul
receptor
viral
inhibit
steric
specif
bind
margin
activ
cell
local
drainag
lymph
node
site
viral
replic
studi
shown
tcell
prolifer
inhibit
high
antigen
concentr
without
affect
product
ceredig
corradin
interact
viru
lymphocyt
gener
occur
readili
cell
activ
splitter
eskra
one
would
expect
case
infect
use
primari
bovin
cell
tcell
clone
live
decreas
viabil
without
replic
cell
therefor
support
fact
virus
alter
tcell
function
without
replic
within
cell
without
induct
antigenspecif
tsuppressor
cell
alter
tcell
function
may
also
induc
virusspecif
glycoprotein
releas
viral
replic
isfort
et
al
rea
et
al
thu
viral
infect
presenc
viral
product
releas
virusinfect
cell
alter
lymphocyt
function
even
viru
replic
lymphocyt
indirect
effect
toxic
solubl
factor
induc
virus
affect
function
integr
lymphocyt
record
wainwright
et
al
furthermor
viral
infect
also
induc
product
ifn
known
immunomodulatori
activ
bielefeldt
ohmann
et
al
babiuk
et
al
ifn
product
nasal
passag
evid
within
day
viral
infect
although
littl
free
ifn
detect
plasma
follow
viru
infect
respiratori
tract
possibl
rapidli
cell
associ
therebi
alter
lymphocyt
reactiv
studi
involv
pharmacokinet
clearanc
ifn
clearli
demonstr
exogen
ifn
rapidli
clear
halflif
approxim
hour
coupl
observ
ifn
dramat
alter
lymphocyt
function
suggest
possibl
highli
like
bielefeldt
ohmann
ifn
shown
inhibit
lymphocyt
prolifer
uitro
reduc
cell
respons
pma
griebel
et
al
unpublish
observ
observ
bovin
ifn
activ
enhanc
elev
temperatur
letchworth
carmichael
maxim
immunosuppress
correl
peak
temperatur
respons
ifn
nasal
secret
suggest
even
low
level
serum
ifn
may
play
import
role
reduct
lymphocyt
reactiv
bacteria
like
virus
reduc
effect
immun
respons
number
direct
indirect
suppress
mechan
indirect
mechan
includ
express
virul
factor
reduc
antigen
antigen
shift
product
iga
proteas
resist
degrad
phagocyt
cell
format
cell
walldefici
l
form
smith
respiratori
bacteri
infect
virul
factor
poor
immunogen
includ
product
capsular
materi
interfer
process
phagocytosi
opson
antibodi
complement
evid
capsular
polysaccharid
pneumococc
bacteria
protein
streptococci
smith
densen
mandel
bacteria
inhibit
bactericid
activ
macrophag
granulocyt
block
oxygendepend
oxygenindepend
kill
mechan
resist
toxic
effect
ro
enzymat
action
lysosom
enzym
proteas
escap
phagocyt
vacuol
cytoplasm
mycobacterium
tuberculosi
good
exampl
bacterium
capabl
surviv
phagocyt
cell
mechan
surviv
relat
prevent
phagosomelysosom
fusion
lowri
et
al
fusion
occur
resist
lysosom
enzym
armstrong
hart
resist
kill
jackett
et
al
mechan
tuberculosi
resist
intracellular
kill
relat
presenc
sulfat
glycolipid
bacterium
cell
wall
draper
correl
found
increas
level
cyclic
amp
lowri
et
al
presenc
polyglutam
acid
draper
product
ammonia
gordon
et
al
bacteri
catalas
walker
pasteurella
haemolytica
speci
also
abl
circumv
phagocyt
effect
macrophag
neutrophil
surviv
intracellular
environ
lawman
et
al
unpublish
observ
reason
surviv
unclear
howev
pasteurellu
strain
capabl
produc
cytotoxin
log
phase
growth
detriment
bovin
leukocyt
shewan
wilki
vitro
bactericid
studi
evid
phagocyt
ingest
bacteria
undergo
morpholog
chang
ke
cytoplasm
swell
extrus
cytoplasm
nuclear
swell
major
phagocyt
cell
nonviabl
assess
trypan
blue
dye
exclus
surviv
bacteria
bovin
phagocyt
neutrophil
also
shown
haemophilu
somnu
czuprynski
hamilton
bacteria
pathogen
mucos
surfac
includ
respiratori
tract
haemophilu
influenza
streptococcu
pneumonia
abl
produc
excret
iga
proteas
kornfeld
plaut
abil
bacteri
iga
proteas
cleav
immunoglobulin
molecul
fab
fc
fragment
may
import
reduc
biolog
activ
antibodi
ie
opson
addit
effect
affin
antigen
bind
may
affect
kornfeld
plaut
gener
immun
respons
complex
phenomenon
involv
cellcel
interact
solubl
factor
therefor
gener
specif
immun
respons
mani
stage
pathogen
bacteria
may
abl
induc
suppress
campa
direct
effect
immun
respons
involv
induct
specif
suppressor
cell
lymphocyt
activ
macrophag
klimpel
henney
wade
et
al
antiisotyp
antibodi
respons
also
induc
respons
antigen
furthermor
antiidiotyp
respons
may
import
either
bind
antigen
receptor
activ
suppressor
cell
siskind
et
al
eichman
although
provid
exampl
bacteria
may
evad
immun
system
even
caus
immunosuppress
mechan
induc
specif
immun
suppress
respiratori
tract
mucos
surfac
fulli
understood
addit
alter
immun
respons
bacteria
also
aid
replic
virus
thu
one
prerequisit
infect
myxovirus
paramyxovirus
cleavag
surfac
glycoprotein
lazarowitz
et
al
scheid
choppin
recent
evid
suggest
colon
haemophilu
influenza
result
enhanc
viru
infect
due
releas
proteolyt
enzym
bacteria
cleav
viral
hemagglutinin
protein
tashiro
et
al
occur
viru
bacteria
benefit
viru
allow
better
adher
bacteria
due
cell
surfac
chang
ramphal
et
al
bacteria
turn
releas
proteas
enhanc
viru
infect
cell
clinic
observ
human
anim
well
experiment
studi
anim
suggest
stress
associ
increas
suscept
viral
bacteri
pneumonia
stephen
pennington
nugent
pesanti
filion
et
al
even
though
exact
mechan
wherebi
increas
suscept
occur
complet
elucid
stress
alter
endocrin
gland
function
import
respons
bodi
stress
secret
adenocorticotrop
hormon
acth
turn
stimul
synthesi
secret
cortisol
stephen
high
cortisol
level
may
deleteri
effect
nonspecif
antigenspecif
defens
mechan
keller
et
al
hirschberg
et
al
forslid
hed
fauci
crabtre
et
al
chretien
garagusi
zor
et
al
taylor
et
al
roth
et
al
pennington
nugent
pesanti
nair
schwartz
bielefeldt
ohmann
et
al
therebi
increas
individu
suscept
invad
microorgan
stephen
filion
et
al
mani
case
stress
associ
crowd
individu
exposur
new
environ
includ
new
microorgan
increas
infect
rate
occur
frequent
armi
recruit
feedlot
situat
moreov
high
cortisol
level
may
caus
reactiv
latent
infect
pastoret
et
al
davi
duncan
either
direct
alter
viral
replic
nutter
doeherti
costa
et
al
suppress
immun
function
control
state
latenc
wildi
et
al
babiuk
rous
reactiv
viral
infect
may
lower
resist
secondari
bacteri
infect
mechan
dealt
section
review
evid
suggest
peripher
nervou
system
modul
immunolog
respons
mucos
surfac
payan
goetzl
present
known
stress
modul
respons
combin
stress
viral
infect
product
endorphin
play
import
role
reduc
resist
pneumonia
age
individu
repres
clinic
problem
increas
magnitud
popul
age
thu
although
preval
viral
bacteri
infect
person
year
age
much
greater
normal
popul
larg
percentag
individu
requir
hospit
infect
occur
despit
extens
care
pulmonari
infect
lead
caus
death
person
year
age
older
kovar
furthermor
averag
durat
hospit
much
longer
elderli
pneumonia
younger
individu
present
littl
known
differ
immunobiolog
elderli
compar
middleag
younger
individu
thu
littl
inform
avail
quantiti
qualiti
secret
respiratori
tract
age
individu
versu
younger
peopl
furthermor
possibl
correl
directli
defici
immun
function
inadequaci
inflammatori
respons
occurr
either
colon
pneumonia
elderli
phair
et
al
thu
consider
amount
investig
requir
elucid
elderli
suscept
lifethreaten
pneumonia
follow
even
mild
viru
infect
individu
suggest
made
increas
suscept
due
declin
mucociliari
transport
abnorm
ciliat
epitheli
cell
line
tracheobronchi
tree
well
quantiti
distribut
viscoelast
secret
coat
airway
howev
remain
investig
one
major
factor
may
involv
enhanc
sever
pneumonia
pattern
respir
elderli
versu
younger
popul
thu
suggest
elderli
much
greater
risk
nocturn
aspir
result
much
larger
number
bacteria
enter
lower
lung
specif
bacteri
coloni
may
end
aspir
lung
caus
pneumonia
occur
even
minor
viral
infect
caus
minim
depress
specif
nonspecif
defens
may
suffici
prevent
elimin
bacteri
microcoloni
aspir
lung
present
context
definit
immunopatholog
restrict
lung
injuri
caus
immunolog
mechan
induc
invad
microorgan
immunolog
defens
per
se
alreadi
dealt
preced
section
role
leukocyt
inflam
lung
contribut
coagul
fibrinolyt
system
well
mediat
inflammatori
event
lung
comprehens
review
slauson
ward
malik
staub
gener
basi
larsen
henson
review
mediat
inflamm
davi
et
al
role
arachidon
acid
deriv
inflamm
roubin
et
al
pathobiolog
effect
macrophagederiv
plateletactiv
factor
beyond
scope
highlight
aspect
pathogenesi
pulmonari
immunopatholog
thu
comprehens
overview
reader
refer
abovecit
review
view
leukocyt
function
pulmonari
defens
must
taken
account
cell
obviou
valu
defend
lung
microbi
invad
also
one
major
mediat
tissu
injuri
produc
releas
potent
inflammatori
mediat
complement
factor
prostaglandin
larsen
henson
unanu
lysosom
product
includ
acid
hydrolas
neutral
proteas
klempner
et
al
lonki
mccarren
ro
ward
gerberick
et
al
product
may
injuri
effect
right
specif
substrat
cleavag
direct
cytotox
cell
activationsuppress
holt
also
amplifi
effect
develop
pulmonari
inflammatori
respons
via
divers
effect
kinin
gener
complement
cleavag
control
leukotoxin
gener
plasminogenindepend
system
intracellular
extracellular
fibrinolysi
review
slauson
involv
arachidon
acid
deriv
lung
inflamm
repres
complic
pictur
variou
product
agonist
antagonist
effect
may
produc
cell
type
endotheli
epitheli
cell
result
effect
may
therefor
reflect
degre
imbal
variou
agent
davi
et
al
slauson
addit
appear
consider
speci
variat
effect
thromboxan
prostacyclin
arachidon
acid
product
well
variat
amount
produc
respons
particular
stimulu
viru
higg
et
al
davi
et
al
complement
factor
deriv
via
altern
pathway
c
activ
shown
produc
select
enzym
lysosom
acid
hydrolas
secret
macrophag
schorlemm
et
al
b
may
consider
import
relat
lung
infect
mani
microorgan
activ
altern
complement
pathway
local
system
fearon
austen
cooper
oldston
bielefeldt
ohmann
babiuk
therebi
indirectli
caus
select
enzym
releas
subsequ
tissu
injuri
addit
system
c
activ
shown
promot
acut
lung
injuri
induc
sequestr
pmn
lung
interstiti
capillari
perhap
via
involv
arachidon
acid
deriv
imasawa
osifchin
golditz
movat
activ
pmn
subsequ
produc
ro
mediat
acut
lung
microvascular
injuri
martin
bass
et
al
fox
et
al
english
luken
immedi
follow
tissu
reaction
insult
harlan
callahan
hoover
et
al
slauson
also
grow
evid
macrophagederiv
tumor
necrosi
factor
tnfa
may
intim
involv
inflammatori
immunoregulatori
reaction
either
directli
indirectli
induc
cytokin
ruddl
remain
determin
whether
mechan
oper
viralbacteri
infect
lung
possibl
implic
might
although
much
still
remain
done
complet
complex
pictur
immunopatholog
scenario
lung
obviou
possibl
circumv
event
limit
complex
process
initi
thu
best
strategem
seem
avoid
infect
first
place
induct
specif
immun
andor
modul
nonspecif
specif
immun
defens
mechan
state
import
avoid
initi
pneumonia
initi
host
may
contribut
immunopatholog
sever
diseas
mind
control
direct
number
area
immun
viral
bacteri
pathogen
use
antivir
antibacteri
therapeut
agent
use
immunomodul
enhanc
either
nonspecif
specif
defens
mechan
especi
import
viral
infect
immunosuppress
one
major
underli
caus
increas
suscept
secondari
bacteri
infect
strategi
import
consid
time
administr
deliveri
specif
agent
ensur
efficaci
thu
treatment
antibiot
extens
lung
damag
bacteri
microcoloni
format
occur
littl
valu
sinc
antibiot
penetr
microcoloni
host
respons
infect
lead
immunopatholog
antibiot
use
select
defin
infect
manner
result
cure
reason
cost
minim
damag
environ
recommend
use
subclin
dose
anim
feed
prevent
respiratori
infect
anim
unfortun
practic
often
use
sinc
virus
involv
respiratori
infect
enter
via
respiratori
tract
replic
respiratori
epithelium
crucial
ensur
local
immun
site
entri
thu
earli
intervent
greatli
reduc
environment
alter
respiratori
tract
caus
virus
well
subsequ
immunosuppress
associ
viru
infect
although
immun
induc
intramuscular
immun
live
kill
viral
vaccin
often
accept
local
immun
attenu
vaccin
potenti
effkaci
thu
current
inactiv
vaccin
given
intramuscularli
effect
influenza
virus
antigen
type
meyer
et
al
potenti
advantag
live
attenu
vaccin
includ
stimul
mucos
system
immun
recent
advanc
area
includ
product
delet
mutant
temperaturesensit
coldadapt
mutant
case
segment
virus
influenza
possibl
develop
coldadapt
temperaturesensit
mutant
temperaturesensit
lesion
number
differ
segment
viru
cocultiv
coldadapt
temperaturesensit
mutant
wildtyp
viru
vaccin
interest
result
varieti
differ
reassort
contain
hemagglutinin
neuraminidas
viru
interest
temperaturesensit
segment
attenu
viru
vaccin
thu
possibl
isol
master
strain
contain
six
rna
gene
attenu
coldadapt
viru
two
gene
encod
surfac
glycoprotein
wildtyp
viru
attenu
reassort
vaccin
infecti
immunogen
rel
stabl
genet
often
nonreactogen
administ
intranas
human
lamontagn
et
al
exampl
live
attenu
vaccin
respiratori
viral
infect
includ
bovin
herpesviru
bhvl
infect
cattl
one
major
initi
secondari
bacteri
infect
possibl
herpesvirus
induc
delet
genom
correspond
tk
gene
viru
kit
et
al
result
delet
viru
still
replic
respiratori
epithelium
anim
howev
degre
replic
system
spread
latenc
dramat
reduc
stanberri
et
al
experi
need
conduct
order
determin
whether
inde
minim
immunosuppress
tk
delet
mutant
whether
still
predispos
anim
secondari
bacteri
infect
especi
stress
vaccin
entri
feedlot
recent
advanc
recombin
dna
technolog
great
potenti
product
wide
varieti
differ
subunit
vaccin
respiratori
infect
approach
appear
especi
relev
produc
vaccin
virus
replic
well
cultur
attenu
eas
furthermor
import
virus
may
genet
unstabl
revers
virul
may
problem
live
attenu
vaccin
present
larg
number
import
antigen
epitop
present
respiratori
virus
identifi
either
synthes
use
synthet
peptid
technolog
clone
variou
express
system
bennink
et
al
norrbi
although
subunit
vaccin
inject
intramuscularli
therefor
potenti
induc
high
level
circul
antibodi
gener
produc
good
local
immun
order
overcom
impedi
consider
amount
effort
focus
deliv
subunit
vaccin
mucos
surfac
abl
stimul
system
immun
also
induc
local
immun
content
within
next
year
intramuscular
vaccin
administ
way
abl
induc
local
immun
well
system
immun
present
larg
number
compound
identifi
potenti
antivir
activ
vitro
number
virus
involv
initi
respiratori
diseas
streissl
et
al
although
compound
either
test
prove
effect
v
virus
respiratori
tract
gangemi
et
al
import
advanc
made
area
last
decad
warrant
seriou
consider
potenti
applic
drug
control
viral
infect
respiratori
tract
section
discuss
potenti
site
activ
select
number
drug
specul
applic
respiratori
tract
infect
addit
limit
use
antivir
drug
infect
address
problem
deliveri
mainten
drug
site
infect
prevent
initi
infect
rather
therapi
emphas
respiratori
infect
viru
infect
target
antivir
drug
must
site
uniqu
viru
physiolog
effect
specif
cell
respiratori
tract
case
viru
infect
antivir
drug
must
direct
variou
stage
viru
replic
cycl
viru
attach
penetr
uncoat
macromolecular
synthesi
viral
matur
assembl
regardless
stage
viru
replic
antivir
drug
target
major
problem
use
antivir
drug
control
viralinduc
respiratori
infect
rapid
respiratori
diseas
occur
follow
local
infect
thu
prevent
viral
activ
earli
stage
infect
appear
promis
approach
also
creat
problem
regard
deliveri
mainten
antivir
drug
consider
period
time
within
respiratori
tract
environ
pend
epidem
addit
variou
chemic
use
antivir
drug
applic
ifn
broadspectrum
antivir
continu
gener
interest
sinc
isaac
lindenmann
first
describ
antivir
compound
advent
recombin
dna
technolog
product
recombin
form
ifn
made
econom
use
direct
antivir
agent
respiratori
tract
agent
mani
antivir
compound
need
present
prior
challeng
monto
et
al
turner
et
al
initi
felt
econom
product
ifn
recombin
dna
technolog
would
greatli
facilit
use
respiratori
infect
howev
dose
requir
inhibit
virus
human
symptom
nasal
irrit
observ
follow
prolong
administr
thu
appear
unaccept
side
effect
human
follow
administr
ifna
sinc
varieti
differ
type
ifn
possibl
may
less
problem
induc
advers
clinic
effect
other
thu
one
discount
valu
use
ifn
antivir
local
administr
respiratori
infect
certain
host
speci
much
suscept
advers
side
effect
local
administr
ifn
other
exampl
cattl
experi
intoler
extrem
high
dose
ifnaadminist
intranas
addit
direct
antivir
effect
ifn
appear
import
role
reduc
respiratori
viru
replic
indirectli
stimul
immun
system
effect
manipul
immun
system
variou
lymphokin
achiev
comprehens
complex
interact
lymphokin
immun
system
requir
thu
import
understand
specif
arm
immun
system
requir
stimul
specif
lymphokin
lymphokin
combin
would
best
meet
need
knowledg
avail
possibl
regul
immun
system
way
would
resist
viral
infect
secondari
bacteri
superinfect
howev
ifn
lymphokin
administ
use
judici
inform
regard
type
ifn
dose
rout
administr
mechan
respons
either
antivir
state
immunomodul
need
determin
primari
interest
clinic
investig
conduct
bovin
human
ifnci
concern
antivir
affect
compound
howev
found
prevent
treatment
calv
bovin
ifna
benefici
effect
clinic
perform
experiment
viralbacteri
pneumonia
ship
fever
without
significantli
reduc
viru
replic
nasal
passag
therefor
assum
ifn
overal
effect
diseas
situat
modul
immun
respons
overal
effect
recombin
bovin
ifna
bovin
macrophag
pmn
might
character
activ
appear
influenc
particular
function
cell
type
selectionthat
either
enhanc
inhibit
detect
affect
bielefeldt
ohmann
et
al
similar
effect
observ
lymphokin
speci
includ
human
thu
use
appropri
deliveri
system
combin
lymphokin
possibl
modul
select
arm
immun
system
requir
combat
infect
activ
way
result
immunopatholog
present
review
identifi
virus
alter
host
suscept
bacteri
infect
alter
environment
condit
lung
favor
bacteri
replic
well
suppress
host
defens
mechan
prevent
clearanc
bacteria
mani
instanc
interact
extrem
complex
similar
mani
virus
viru
overcom
initi
host
defens
mechan
includ
local
antibodi
mucu
viru
initi
tissu
damag
result
direct
replic
within
epitheli
cell
line
mucos
surfac
respiratori
tract
result
viru
infect
host
cell
respond
produc
varieti
mediat
includ
variou
type
interferon
alter
viru
replic
host
respons
replic
also
produc
byproduct
viru
infect
capabl
initi
inflammatori
process
turn
releas
mediat
modifi
lung
defens
mechan
encourag
bacteri
adher
growth
bacterium
turn
releas
chemotact
factor
encourag
infiltr
specif
effector
cell
lung
effector
cell
caus
tissu
damag
immunopatholog
encourag
rapid
bacteri
growth
may
result
death
anim
order
abl
control
complic
scenario
import
either
prevent
initi
infect
virus
reduc
degre
immunosuppress
bacteri
clearanc
occur
rapidli
microcoloni
format
extens
lung
damag
occur
larg
amount
bacteri
replic
lung
damag
present
use
antibiot
gener
limit
valu
schemat
illustr
complex
variou
interact
counteract
occur
virusbacteri
synergist
interact
present
fig
